Mendeleev Commun., 2019, 29, 181–183
H(3)
N(3)
H(7)
N(7)
C(8)
N(5)
HCl for 4 h, which is a common procedure for benzimidazole
synthesis,12 to get identical DIP·2HCl in 30% yield. Salt DIP·2HCl
was converted into hydrate form (DIP·H2O) by heating in aqueous
ammonia. Both hydrate and hydrochloride forms were tested in a
model reaction of nucleophilic aromatic substitution with 4-fluoro-
nitrobenzene (Scheme 2).¶
C(6)
C(4)
C(2)
N(1)
C(12)
C(10)
N(9)
H(9)
C(11)
H(1)
NO2
N
Figure 1 General view of the dication of DIP·2H+ (5·2HCl) in thermal
ellipsoid representation (p = 50%). Chloride anions are omitted for clarity.
N
N
K2CO3
DMA
+
HN
NH
F
NO2
5
6
compound 3 a complex mixture of hardly identified substances
was formed. The reaction was incomplete even after 3 days, so
we decided to carry out the process at higher pressure in an
autoclave. Under these conditions, the desired DIP 5 was obtained
in 31% yield‡ (see Scheme 1). For better purification, HCl was
used to recrystallize DIP in hydrochloride form, and the obtained
crystals were characterized by the X-ray data (Figure 1).§
The molecular structure of compound 5 is the first example of
the crystal containing the 1,7-dihydrodiimidazo[4,5-b:4',5'-e]-
pyridine heterocyclic system. Due to dicationic character, the
bond lengths C–N with atoms C(2) and C(8) in five-membered
rings of the hererocycles are almost equalized, as well as C–N
bonds with exocyclic to pyridine ring. The four H atoms attached
to nitrogen atoms participate in N–H···Cl hydrogen bonds of the
moderate strength [N···Cl 3.056(4)–3.102(4) Å], connecting the
ions into zigzag-like layers.
N
N
N
N
N
N
N
N
+
N
N
O2N
NO2 O2N
(7 : 3)
7a
7b
Scheme 2
The conditions of the model reaction were chosen to be close
to the polymer synthesis with bis(benzimidazole) monomers.4,5
According to our previous experience, sonification of the monomer
with K2CO3 at the beginning of the synthesis increases the
reaction rate and helps to obtain polymers with higher molecular
weights. The role of K2CO3 here is to deprotonate NH from the
imidazole cycle, and so, additional quantity of K2CO3 is required
to scavenge HCl from salt DIP·2HCl. Theoretically, DIP has five
tautomeric forms, so one may suppose that this could affect
the reaction outcome.Yet, the deprotonation of these forms leads
to a single anion structure. The nitrogen atom in the central
Alternatively, DIP 5 was synthesized via tetraamine pathway
(see Scheme 1). 2,3,5,6-Teraaminopyridine 4 hydrochloride was
prepared by a known method in autoclave,5 that required large
amounts of HCl and THF for its sedimentation. The obtained
tetraamine 4 was refluxed in a mixture of formic acid and 18%
‡
2,6-Diamino-3,5-dinitropyridine 3 (10 g, 5 mmol), Pd/C (0.7 g, 5%),
formic acid (225 ml, 90%) and methanol (75 ml) were placed in a 500 ml
autoclave, the vessel was filled with hydrogen (90 atm). The autoclave
was heated at 100°C for 12 h, then cooled to room temperature to reveal
that 15 atm of H2 were consumed. The mixture was concentrated with
rotary evaporator at 80°C (140 mbar), dissolved in hot concentrated HCl
(200 ml) and filtered from the catalyst. The precipitate obtained after
cooling was filtered and once again recrystallized from HCl with addition
of activated charcoal to obtain 3.67 (31%) of pure DIP·2HCl as yellowish
crystals. 1H NMR (400 MHz, D2O) d: 9.07 (s, 2H), 8.32 (s, 1H). 1H NMR
(400 MHz, DMSO-d6, NEt3) d: 8.39 (s, 2H), 8.18 (s, 1H). Found (%):
Cl, 30.43. Calc. for C7H5N5·2HCl (%): Cl, 30.55.
¶
Salt DIP·2HCl (0.464 g, 2 mmol), K2CO3 (0.691 g, 5 mmol), N,N-di-
methylacetamide (DMA, 5 ml) and toluene (2 ml) were placed in a
two-necked flask with a mechanical stirrer and argon inlet and sonicated
at 80°C for 20 min in ultrasonic bath. Then 4-fluoronitrobenzene (0.564 g,
4 mmol) was added, and the flask was placed into a silicon bath and
heated up to 110°C. Soon the mixture acquired a rich violet color, which
then faded into light yellow. After 20 h of heating the mixture was poured
into water, the precipitate was filtered off, washed and dried in vacuo to
give 0.73 g (87%) of the product.
Similar procedure was performed for DIP·H2O (0.354 g, 2 mmol) with
a reduced quantity of K2CO3 (0.414 g, 3 mmol) and an additional 1 h
heating of the reaction mixture at 110°C to remove the hydrate water
before the addition of 4-fluoronitrobenzene, 0.836 g (99%) of the product
were obtained.
Salt DIP·2HCl (1 g, 4.7 mmol) was heated in 20 ml of 10% aq. NH3,
filtered and dried at 50°C in vacuo to obtain white powder of neutralized
form DIP·H2O in quantitative yield (0.76 g). 1H NMR (400 MHz,
DMSO-d6) d: 12.87 (s, 2H), 8.40 (s, 2H), 8.19 (s, 1H). 13C NMR
(101 MHz, DMSO-d6) d: 148.51, 143.94, 128.60, 111.21. Found (%):
C, 47.73; H, 3.83; N, 39.51. Calc. for C7H5N5·H2O (%): C, 47.46; H, 3.98;
N, 39.53. Lit.,9 1H NMR (500 MHz, DMSO-d6) d: 12.77–12.72 (s, 2H),
8.38 (s, 2H), 8.18–8.14 (s, 1H).
The reaction product (100 mg) was dissolved in DMA (6 ml), centri-
fuged for 1 h at 3000 rpm, the supernatant was separated from the residue
of ‘trans’ (7b) product (19 mg) and precipitated with water to give 60 mg
of ‘cis-1’ (7a) product. NMR spectra of the products are presented and
discussed in Online Supplementary Materials.
§
Crystal data for 5: monoclinic, space group P21, a = 4.7530(6), b =
= 10.9303(14) and c = 8.6048(11) Å, b = 95.439(3)°, V = 445.02(10) Å3,
Z = 2 (Z' = 1), dcalc = 1.732 g cm–3, R1 = 0.0342 [for 2301 reflections with
I > 2s(I)], wR2 = 0.0819, GOF = 1.030.
Crystal data for 7a: monoclinic, space group C2/c, a = 22.399(3), b =
= 14.2557(16) and c = 7.1186(8) Å, b = 99.297(2)°, V = 2243.2(4) Å3,
Z = 4 (Z' = 0.5), dcalc = 1.461 g cm–3 (without SQUEEZed solvent), R1 =
= 0.0424 [for 2547 reflections with I > 2s(I)], wR2 = 0.1190, GOF = 1.054.
Crystal data for 7b: monoclinic, space group P21/n, a = 10.0092(3),
b = 13.7495(4) and c = 15.3130(5) Å, b = 94.4884(16)°, V = 2100.93(11) Å3,
Z = 2 (Z' = 0.5), dcalc = 1.716 g cm–3, R1 = 0.0532 [for 5034 reflections
with I > 2s(I)], wR2 = 0.1371, GOF = 1.007.
The diffraction experiment for 5 was performed on a Bruker Smart
Apex II, and for 7a,b on a Bruker Apex DUO diffractometer; for all
samples at 120 K using MoKa radiation (l = 0.71072 Å).
CCDC 1868389–1868391 contain the supplementary crystallographic
data for this paper. These data can be obtained free of charge from The
Major product, 1,7-bis(4-nitrophenyl)-1,7-dihydrodiimidazo[4,5-b:4',5'-e]
pyridine 7a: mp 370–380°C. H NMR (400 MHz, DMSO-d6) d: 9.09
-
1
(s, 2H), 8.52 (s, 1H), 8.47 (d, 4H, J 8.9 Hz), 8.15 (d, 4H, J 8.9 Hz).
13C NMR (101 MHz, DMSO-d6) d: 154.34, 146.95, 146.46, 141.48, 126.09,
124.53, 123.31, 103.31. Found (%): C, 55.99; H, 3.01; N, 23.88. Calc. for
C19H11N7O4·H2O (%): C, 54.42; H, 3.12; N, 23.38.
Minor product, 1,5-bis(4-nitrophenyl)-1,5-dihydrodiimidazo[4,5-b:5',4'-e]-
pyridine 7b: mp > 400°C. 1H NMR (400 MHz, CF3COOD) d: 10.44
(s, 1H), 10.37 (s, 1H), 9.51 (s, 1H), 9.07 (d, 2H, J 8.7 Hz), 9.03 (d, 2H,
J 8.4 Hz), 8.59 (d, 2H, J 8.7 Hz), 8.46 (d, 2H, J 8.4 Hz). 13C NMR
(101 MHz, CF3COOD) d: 153.13, 152.52, 148.95, 148.66, 146.52, 146.39,
140.48, 139.98, 130.02, 129.85, 129.45, 129.29, 128.37, 127.88. Found (%):
C, 54.44; H, 3.24; N, 23.03. Calc. for C19H11N7O4·H2O (%): C, 54.42;
H, 3.12; N, 23.38.
– 182 –